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Introduction: Stress echocardiography is the combination of 2D echocardiography with physical, pharmaco-
logical or electrical stress. The diagnostic endpoint of the detection of myocardial ischemia is the induction 
of a transient change in regional function during stress.1 Myocardial ischemia results in a typical “cascade” 
of events in which the various markers are hierarchically ranked in a well-defined time sequence. Flow 
heterogeneity between subendocardial and subepicardial perfusion is the forerunner of ischemia, followed 
by metabolic changes, alteration in regional mechanical function, and only at a later stage by electrocardio-
graphic (ECG) changes, global left ventricular dysfunction (LV) and pain.2 Wall motion and perfusion or coro-
nary flow reserve (CFR) changes are highly accurate, and more accurate than ECG changes for detection and 
location of underlying coronary artery disease. However, wall motion is more specific and requires ischemia; 
perfusion changes are more sensitive and may occur in the absence of true ischemia (microvascular dis-
ease, or LV hypertrophy).1 The three most common ischemic stressor are exercise, dobutamine, and vasodi-
lators (dipyridamole, adenosine). They are equally potent for inducing wall abnormalities in the presence of 
a critical epicardial coronary artery stenosis. Dobutamine and exercise manly act through increased myo-
cardial oxygen demand. Vasodilators act by stimulating 
A2 adenosinergic receptors present on the endothelial 
and smooth muscle cells of coronary arterioles and in-
duce ischemia due to reduced subendocardial flow sup-
ply subsequent to inappropriate arteriolar vasodilatation 
and steal phenomena.1 Dipyridamole was the first phar-
macological stress agent used for the diagnosis of coro-
nary artery disease, with a pioneering indication pro-
posed in Europe for the identification of ischemia during 
12-lead ECG3, and later in the USA by Lance Gould as hy-
peremic stress perfusion imaging.4 Dipyridamole stress 
echocardiography pioneered in the year of 1985 (Picano 
et al). The safety record of high dose dipyridamole is well 
established on the basis of large scale multicentric stud-
ies with data from thousands of patients. The incidence 
of major complications, i.e. myocardial infarction, atrio-
ventricular block, cardiac asystole, sustained ventricular 
tachycardia, is about 1/1500 cases. The mortality rate is 
about 1/10000 cases, similar to that of the exercise stress 
test. Dipyridamole has a better safety profile than when 
stress testing with dobutamine, where the incidence of 
major adverse reactions is about 1/300 studies.5 Many 
centers from 1988 until today, have used high doses ad-
ministered in a short time (syringe-based infusion of 0.84 mg/kg). Later, some studies were reproduced with 
these doses, and today, most centers worldwide use high dose delivered in 4-6 min.6
Center experience: In 2017 we started to perform stress echocardiography in Čakovec County Hospital. The 
first method was exercise echocardiography using treadmill protocol, with imperative do accomplish post-
exercise imaging as soon as possible (<1 min from the cessation of exercise) where patient moved immediately 
from treadmill to imaging bed. With this method we have information from exercise stress testing combined 
with echocardiographic wall motions analysis to make final interpretation. The second method and most used 
until recently in our echo lab is standard dobutamine stress protocol, starting with 5 ug/kg/min and increasing 
10, 20, 30 and 40 ug/kg/min. If no endpoint is reached, atropine, usually in dose 0.25 mg, is added to maximal 
dobutamine dose infusion. We are using this method for coronary disease detection, but also low dose protocol, 





Figure 1. Dipyridamole stress echo timeline.
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Recently we started vasodilator stress echocardiography using dipyridamole, and until today, we performed a test on 15 patients. Protocol 
diagram is showed in Figure 1. The dipyridamole dose employed for stress testing was 0.84 mg/kg administered in short time (syringe-based 
infusion at a rate of 0.21 mg/kg/min during 4 minutes). A fast protocol is embraced because is known that high dose protocols in short time 
causes a three- to fourfold increase in coronary blood flow in normals and give best sensitivity and specificity for coronary pathology detec-
tion7. Peak vasodilatation occurs 1 to 2 minutes after the end of infusion and the dipyridamole elimination half-time is 40 minutes which 
enables us enough time for imaging in the period of maximum stress. After image completion we give the antidote aminophylline (blocks 
adenosine receptors) even in negative cases. The antidote can also be used for emergent reversal of adverse dipyridamole-related events 
which we have not encountered in this limited series of tests. If technically feasible due to image quality, we perform measurement of coro-
nary flow reserve in mid to distal left anterior descending artery (LAD) using pulse doppler (Figure 2 and Figure 3) before and after vasodilata-
tion. CFR in many cases adds additional diagnostic value when combined with conventional wall motion analysis. Another tool to increase 
diagnostic accuracy, especially when image quality is impaired, are contrast agents (i.e. Optison) which help to delineate endocardial borders. 
All caffeine-containing foods (coffee, tea, chocolate, bananas, cola drinks) should be avoided for 12 hours before test and all theo-
phylline-containing drugs (aminophylline) should be discontinued for at least 24 hours before test. Very low dose protocols can be 
used (0.28 ug/kg) to identify myocardial viability and have high specificity (higher than dobutamine) but lower sensitivity8. Absolute 
contraindications for dipyridamole stress test are active bronchospasm, 2nd or 3rd degree AV block and systolic blood pressure <90 
mmHg. Relative contraindications are methylxanthine use and remote history of restrictive airway disease. 
Conclusion: Dipyridamole stress echocardiography can be used as a preferred stress test for the detection of coronary artery disease 
in patients unable to exercise and with contraindications to dobutamine (tachyarrhythmias, uncontrolled blood pressure). It is techni-
cally easier than exercise or dobutamine stress tests since image quality is less degraded by tachycardia, hyperventilation and hyper-
contractility. The test is equally accurate in comparison with dobutamine, but technically easier and safer9. In the future, dipyridamole 
test is planned to be the default method for pharmacological stress in our laboratory supported with contrast agents when necessary. 
Contrast perfusion stress echocardiography is the next planned step in years to come.
Figure 3. distal left anterior descending artery – pW max 
diastolic velocity.
Figure 2. Distal left anterior descending artery – color doppler.
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